Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey )
ClinicalTrials.gov Identifier:
NCT00391677
First received: October 20, 2006
Last updated: September 27, 2012
Last verified: September 2012

October 20, 2006
September 27, 2012
January 2007
June 2011   (final data collection date for primary outcome measure)
  • Observational ratings of in-group attentiveness [ Time Frame: Measured two times per week for 16 weeks ] [ Designated as safety issue: No ]
  • Observational ratings of in-group attentiveness in non-study groups [ Time Frame: Measured at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Changes in knowledge of information about social skills taught in the study [ Time Frame: Measured at pre- and post-treatment and at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Changes in ability to demonstrate behavioral skills taught in the study [ Time Frame: Measured at pre- and post-treatment and at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Level of social functioning [ Time Frame: Measured at pre- and post-treatment and at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Measured 6 months post-intervention: Observational ratings of in-group attentiveness
  • Observational ratings of in-group attentiveness in non-study groups
  • Changes in knowledge of information about social skills taught in the study
  • Changes in ability to demonstrate behavioral skills taught in the study
  • Level of social functioning
Complete list of historical versions of study NCT00391677 on ClinicalTrials.gov Archive Site
  • Self-efficacy [ Time Frame: Measured at pre- and post-treatment and at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Working alliance [ Time Frame: Measured at pre- and post-treatment and at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Satisfaction with treatment [ Time Frame: Measured at pre- and post-treatment and at Month 6 follow-up ] [ Designated as safety issue: No ]
  • Measured 6 months post-intervention: Self-efficacy
  • Working alliance
  • Satisfaction with treatment
Not Provided
Not Provided
 
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia
Effectiveness Trial of Attention Shaping for Schizophrenia

This study will evaluate the effectiveness of attention shaping procedures in improving attentiveness and learning abilities in people undergoing psychosocial skills training treatment for schizophrenia.

Schizophrenia is a disabling mental disorder that can interfere with a person's ability to function both alone and in social situations. Various treatments have been effective in treating schizophrenia, including antipsychotic medications and cognitive therapy. Psychosocial skills training, a type of cognitive therapy, is often used to help people with schizophrenia cope with their condition and improve social functioning in day-to-day life. However, many individuals with schizophrenia experience difficulty paying attention, and this is a significant barrier to successful outcomes in psychosocial skills training interventions. Attention shaping procedures (ASP) is a behavioral intervention that helps individuals with impaired attention capacities to benefit from skills-based treatment. This study will evaluate the effectiveness of ASP in improving attentiveness and learning abilities in people undergoing psychosocial skills training treatment for schizophrenia.

Participants in this 5-month, single-blind study will be randomly assigned to ASP plus basic conversation skills training (BCS), which is a social skills training group, or BCS alone. Training sessions for both groups will be held when participants attend regular hospital visits. During the first month, participants will complete two sessions of interviews, self-report scales, and social and cognitive functional assessments. Over the next 3 months, training sessions for both groups will occur twice a week for approximately 1 hour. ASP sessions will focus on setting goals and increasing the quality and duration of participants' attentiveness during psychosocial interventions. BCS will train participants in the following five skill areas: recognizing verbal and non-verbal cues; starting a friendly conversation; keeping conversation going; ending a conversation politely; and incorporating all of these skills together. During the last month, participants will attend two interview sessions lasting approximately 4 hours each. One follow-up session will occur 6 months after completing the intervention.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Schizophrenia
  • Behavioral: Social skills training with attention shaping procedures
    Social skills training with attention shaping procedures includes behavioral procedures to increase the frequency, intensity, and duration of attentive behaviors and to reduce the frequency of inattentive behaviors.
  • Behavioral: Social skills training without attention shaping
    Social skills training without attention shaping is based on the UCLA Basic Conversation Skills Training Module, used without attention shaping procedures.
  • Experimental: 1
    Participants will receive social skills training with attention shaping procedures
    Intervention: Behavioral: Social skills training with attention shaping procedures
  • Active Comparator: 2
    Participants will receive social skills training without attention shaping procedures
    Intervention: Behavioral: Social skills training without attention shaping

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
June 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of schizophrenia, as confirmed by a diagnostic interview
  • Has experienced difficulty paying attention while in groups during a treatment program, as determined by program staff
  • Has experienced problems with social skills, as determined by program staff and study clinicians
  • Social skill deficits, as determined by study clinicians

Exclusion Criteria:

  • Diagnosis of mental retardation (including borderline or mild mental retardation)
  • Diagnosis of autism, Asperger's syndrome, or another childhood disorder involving learning or relating to other people
  • History of a neurological disorder, including epilepsy, traumatic brain injury with loss of consciousness, coma, stroke, Parkinson's disease, etc.
  • Diagnosis of active substance abuse (history of a substance abuse disorder without a current substance abuse problem will not be a criterion for exclusion)
Both
18 Years to 55 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00391677
R01 MH074650, R01MH074650, DATR A2-A1SZ
Yes
Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey )
University of Medicine and Dentistry of New Jersey
National Institute of Mental Health (NIMH)
Principal Investigator: Steven M. Silverstein, PhD University of Medicine and Dentistry of New Jersey
Rutgers, The State University of New Jersey
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP